Gill, P., Dwyer, T., Richards, S., Barrett, T. S., Lopez-Chavez, A., Huffman, D. (2026). Real-world evidence on changes in uptake, sepsis, and costs with dual immunotherapy for first-line NSCLC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20701